Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 85M 60.82M 52.46M 49.35M 44.96M 84.54M 5.77B 583M 227M 2.94B 228M 223M 9.74B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 80.35M 57.49M 49.59M 46.65M 42.5M 79.92M 5.46B 552M 215M 2.78B 216M 211M 9.2B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
76.76% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 2020-04-30 |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | 2018-12-27 |
Roksan Libinaki
COO | Chief Operating Officer | - | 2020-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 2015-04-12 |
Gregory Collier
CHM | Chairman | - | 2018-12-31 |
Kathy Connell
BRD | Director/Board Member | 59 | 2024-04-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 63.64M | ||
| +0.43% | -5.58% | +58.44% | +109.08% | 1,031B | ||
| +1.34% | -1.35% | +51.33% | +67.90% | 641B | ||
| +1.28% | -2.34% | +22.49% | +75.16% | 453B | ||
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | ||
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | ||
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | ||
| +0.86% | -2.21% | +50.72% | +68.46% | 232B | ||
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | ||
| +1.49% | -0.23% | +31.69% | +93.64% | 181B | ||
| Average | -0.47% | -2.98% | +28.74% | +50.19% | 403.31B | |
| Weighted average by Cap. | +0.95% | -3.97% | +37.82% | +66.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 810K 699K 658K 599K 1.13M 76.92M 7.77M 3.03M 39.13M 3.04M 2.98M 130M | 1.24M 886K 764K 719K 655K 1.23M 84.05M 8.5M 3.31M 42.76M 3.33M 3.25M 142M |
| Net income | -3.12M -2.23M -1.93M -1.81M -1.65M -3.11M -212M -21.43M -8.34M -108M -8.39M -8.21M -358M | -4.42M -3.16M -2.73M -2.56M -2.34M -4.39M -300M -30.31M -11.8M -153M -11.86M -11.61M -506M |
| Net Debt | -1.3M -929K -801K -754K -686K -1.29M -88.13M -8.91M -3.47M -44.83M -3.49M -3.41M -149M | -4.65M -3.33M -2.87M -2.7M -2.46M -4.62M -316M -31.91M -12.42M -161M -12.49M -12.22M -532M |
Employees
-
Sector
Pharmaceuticals
















